Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
K022053Substantially Equivalent

Hydragel 7 Lipoprotein(e), Pn 4114 & Hydragel Lipoprotein(e) 15/30 Pn 4134

Sebia, Chelsea MI / Special, Substantially Equivalent

K022053 is the FDA 510(k) clearance record for HYDRAGEL 7 LIPOPROTEIN(E), PN 4114 & HYDRAGEL LIPOPROTEIN(E) 15/30 PN 4134, a class I device, cleared for Sebia on under FDA product code JHO (Electrophoretic Separation, Lipoproteins). FDA records list 7 510(k) clearances for Sebia, from to . As of , FDA records show no recalls naming K022053.

Clearance record

Decision date
Received
(18 days to decision)
Product code
JHO Electrophoretic Separation, Lipoproteins
Regulation
21 CFR 862.1475
Device class
Class I
Review panel
Clinical Chemistry
Applicant
Sebia 13805 Waterloo, Chelsea MI
510(k) summary
Statement
Third party review
No

Clearances, product code JHO

Trailing 12 months

FDA records hold no clearances under product code JHO in the trailing twelve months.

FDA records show no clearances under product code JHO in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code JHO, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260